{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:06:38Z","timestamp":1760267198291},"reference-count":108,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1279,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Ther"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1111\/j.1529-8019.2012.01508.x","type":"journal-article","created":{"date-parts":[[2012,6,14]],"date-time":"2012-06-14T14:33:46Z","timestamp":1339684426000},"page":"99-111","source":"Crossref","is-referenced-by-count":10,"title":["Cutaneous lupus erythematosus"],"prefix":"10.1155","volume":"25","author":[{"given":"Christopher B.","family":"Hansen","sequence":"first","affiliation":[{"name":"Department of Dermatology; University of Utah; Salt Lake City; Utah; USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin W.","family":"Dahle","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Utah; Salt Lake City; Utah; USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2012,6,14]]},"reference":[{"issue":"5","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0001|dth1508-cit-0001","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jaad.2010.02.008","article-title":"Quality of life in cutaneous lupus erythematosus","volume":"64","author":"Klein","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0002|dth1508-cit-0002","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0190-9622(81)80261-7","article-title":"Distinctive cutaneous subsets in the spectrum of lupus erythematosus","volume":"4","author":"Gilliam","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0003|dth1508-cit-0003","first-page":"576","volume-title":"Dubois' lupus erythematosus","author":"Sontheimer","year":"2007"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0004|dth1508-cit-0004","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/archderm.1990.01670250058008","article-title":"Histopathologic comparisons of the subsets of lupus erythematosus","volume":"126","author":"Jerdan","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0005|dth1508-cit-0005","first-page":"15","volume-title":"Cutaneous manifestations of rheumatic disease","author":"Costner","year":"2004"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0006|dth1508-cit-0006","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.0022-202X.2005.23889.x","article-title":"The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus","volume":"125","author":"Albrecht","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0007|dth1508-cit-0007","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.2010.09799.x","article-title":"Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus","volume":"163","author":"Kuhn","year":"2010","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0008|dth1508-cit-0008","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1067\/mjd.2001.114589","article-title":"Phototesting in lupus erythematosus: a 15-year experience","volume":"45","author":"Kuhn","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0009|dth1508-cit-0009","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1034\/j.1600-0781.2000.160604.x","article-title":"Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing photoprovocation test","volume":"16","author":"Stege","year":"2000","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"9","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0010|dth1508-cit-0010","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1002\/art.20426","article-title":"Use of sunscreens to protect against ultraviolet-induced lupus erythematosus","volume":"50","author":"Herzinger","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0011|dth1508-cit-0011","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2009.12.053","article-title":"Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus: a randomized, vehicle-controlled, double-blind study","volume":"64","author":"Kuhn","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"117","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0012|dth1508-cit-0012","first-page":"35620","article-title":"Labeling and effectiveness testing; sunscreen products for over-the-counter human use. Final rule","volume":"76","author":"Food and Drug Administration, HHS","year":"2011","journal-title":"Fed Regist"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0013|dth1508-cit-0013","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0781.2008.00373.x","article-title":"Photoprotective behaviour and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus","volume":"24","author":"Cusack","year":"2008","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"7","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0014|dth1508-cit-0014","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0961203309360807","article-title":"Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region","volume":"19","author":"Cutillas-Marco","year":"2010","journal-title":"Lupus"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0015|dth1508-cit-0015","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2133.2010.09948.x","article-title":"Vitamin D deficiency in patients with cutaneous lupus erythematosus is prevalent throughout the year","volume":"163","author":"Heine","year":"2010","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0016|dth1508-cit-0016","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002954.pub2","article-title":"Drugs for discoid lupus erythematosus","author":"Jessop","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0017|dth1508-cit-0017","first-page":"281","article-title":"Discoid lupus erythematosus. Diagnostic features and evaluation of topical corticosteroid therapy","volume":"25","author":"Roenigk","year":"1980","journal-title":"Cutis"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0018|dth1508-cit-0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2007.02427.x","article-title":"The use of topical calcineurin inhibitors in lupus erythematosus: an overview","volume":"22","author":"Wollina","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0019|dth1508-cit-0019","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.2006.07595.x","article-title":"Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study","volume":"156","author":"Tzung","year":"2007","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0020|dth1508-cit-0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2230.2009.03351.x","article-title":"Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study","volume":"35","author":"Madan","year":"2010","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0021|dth1508-cit-0021","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2010.03.037","article-title":"Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial","volume":"65","author":"Kuhn","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0022|dth1508-cit-0022","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2004.01.044","article-title":"Pimecrolimus 1% cream for cutaneous lupus erythematosus","volume":"51","author":"Krueter","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0023|dth1508-cit-0023","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/rheumatology\/kei093","article-title":"Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus","volume":"44","author":"Tlacuilo-Parra","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0024|dth1508-cit-0024","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2230.2008.03138.x","article-title":"Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study","volume":"34","author":"Barikbin","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0025|dth1508-cit-0025","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000066428","article-title":"Successful treatment of chronic discoid lupus erythematosus of the scalp with imiquimod","volume":"205","author":"Gerdsen","year":"2002","journal-title":"Dermatology"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0026|dth1508-cit-0026","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/BF02850319","article-title":"A case of generalized discoid lupus erythematosus: successful treatment with imiquimod cream 5%","volume":"23","author":"Gul","year":"2006","journal-title":"Adv Ther"},{"issue":"8","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0027|dth1508-cit-0027","first-page":"1022","article-title":"Development of subacute cutaneous lupus erythematosus associated with the use of imiquimod to treat actinic keratoses","volume":"9","author":"Burnett","year":"2010","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0028|dth1508-cit-0028","first-page":"351","article-title":"Cutaneous lupus treated with topical tretinoin: a case report","volume":"47","author":"Seiger","year":"1991","journal-title":"Cutis"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0029|dth1508-cit-0029","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0190-9622(99)70278-1","article-title":"Treatment of localized discoid lupus erythematosus with tazarotene","volume":"41","author":"Edwards","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0030|dth1508-cit-0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D30R49C68V","article-title":"Two cases of refractory discoid lupus erythematosus successfully treated with topical tocoretinate","volume":"17","author":"Terao","year":"2011","journal-title":"Dermatol Online J"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0031|dth1508-cit-0031","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/096120339600500405","article-title":"Ultraviolet-A1 (340-400\u2009nm) irradiation therapy in systemic lupus erythermatosus","volume":"5","author":"McGrath","year":"1996","journal-title":"Lupus"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0032|dth1508-cit-0032","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1529-8019.2007.00131.x","article-title":"New concepts in antimalarial use and mode of action in dermatology","volume":"20","author":"Kalia","year":"2007","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0033|dth1508-cit-0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archderm.1967.01610010007001","article-title":"Immunologic concepts of light reactions in lupus erythematosus and polymorphous light eruptions. I. The mechanism of action of hydroxychloroquine","volume":"96","author":"Lester","year":"1967","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0034|dth1508-cit-0034","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1002\/art.22156","article-title":"Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus","volume":"54","author":"Costedoat-Chalumeau","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0035|dth1508-cit-0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0307-742X(21)00213-7","article-title":"Antimalarial therapy in SLE","volume":"8","author":"Lanham","year":"1982","journal-title":"Clin Rheum Dis"},{"issue":"8","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0036|dth1508-cit-0036","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-4362.1990.tb03464.x","article-title":"Treatment of subacute lupus erythematosus","volume":"29","author":"Furner","year":"1990","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0037|dth1508-cit-0037","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archdermatol.2011.191","article-title":"Response to antimalarial agents in cutaneous lupus erythematosus: a prospective analysis","volume":"147","author":"Chang","year":"2011","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0038|dth1508-cit-0038","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"American Academy of Ophthalmology. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0039|dth1508-cit-0039","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/jid.2011.237","article-title":"Cigarette smoking and response to antimalarials in cutaneous lupus erythematosus patients: evolution of a dogma","volume":"131","author":"Dutz","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0040|dth1508-cit-0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1529-8019.2007.00135.x","article-title":"Methotrexate in dermatology","volume":"20","author":"Bangert","year":"2007","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0041|dth1508-cit-0041","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1067\/mjd.2002.114608","article-title":"Methotrexate treatment for refractory subacute cutaneous lupus erythematosus","volume":"46","author":"Kuhn","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0042|dth1508-cit-0042","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archderm.1994.01690070134027","article-title":"Discoid lupus erythematosus: uccessful treatment with oral methotrexate","volume":"130","author":"Goldstein","year":"1994","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0043|dth1508-cit-0043","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s002960050058","article-title":"Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms","volume":"18","author":"Boehm","year":"1998","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0044|dth1508-cit-0044","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2133.2005.06552.x","article-title":"Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients","volume":"153","author":"Wenzel","year":"2005","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0045|dth1508-cit-0045","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2006.07431.x","article-title":"Methotrexate treatment in cutaneous lupus erythematosus: subcutaneous application is as effective as intravenous administration","volume":"155","author":"Huber","year":"2006","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0046|dth1508-cit-0046","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2340\/0001555565324329","article-title":"Treatment of cutaneous lupus erythematosus with etretinate","volume":"65","author":"Ruzicka","year":"1985","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0047|dth1508-cit-0047","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/archderm.1988.01670060043013","article-title":"Efficiency of acitretin in the treatment of cutaneous lupus erythematosus","volume":"124","author":"Ruzicka","year":"1988","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0048|dth1508-cit-0048","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2133.1992.tb14851.x","article-title":"Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine","volume":"127","author":"Ruzicka","year":"1992","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0049|dth1508-cit-0049","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1346-8138.2005.tb00785.x","article-title":"Hypertrophic lupus erythematosus treated successfully with acitretin as monotherapy","volume":"32","author":"Al-Mutairi","year":"2005","journal-title":"J Dermatol"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0050|dth1508-cit-0050","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/archderm.1986.01660140060018","article-title":"Mechanism-oriented assessment of isotretinoin in chronic or subacute cutaneous lupus erythematosus","volume":"122","author":"Newton","year":"1986","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0051|dth1508-cit-0051","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0190-9622(91)70008-P","article-title":"Isotretinoin for refractory lupus erythematosus","volume":"24","author":"Shornick","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0052|dth1508-cit-0052","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1067\/mjd.2001.114733","article-title":"Dapsone and sulfones in dermatology: overview and update","volume":"45","author":"Zhu","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0053|dth1508-cit-0053","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0190-9622(84)70180-0","article-title":"Annular subacute cutaneous lupus erythematosus responsive to dapsone","volume":"11","author":"McCormack","year":"1984","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0054|dth1508-cit-0054","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1346-8138.1989.tb01284.x","article-title":"Lupus erythematosus profundus - report of a case treated with dapsone","volume":"16","author":"Yamada","year":"1989","journal-title":"J Dermatol"},{"issue":"9","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0055|dth1508-cit-0055","first-page":"1222","article-title":"Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency","volume":"17","author":"Holtman","year":"1990","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0056|dth1508-cit-0056","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2133.1981.tb01711.x","article-title":"Dapsone in the treatment of lupus erythematosus","volume":"104","author":"Ruzicka","year":"1981","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0057|dth1508-cit-0057","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.1982.tb00910.x","article-title":"Dapsone and discoid lupus erythematosus","volume":"106","author":"Coburn","year":"1982","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0058|dth1508-cit-0058","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000249338","article-title":"Dapsone in the treatment of cutaneous lupus erythematosus","volume":"172","author":"Lindskov","year":"1986","journal-title":"Dermatologica"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0059|dth1508-cit-0059","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archderm.142.3.399","article-title":"Lupus erythematosus profundus successfully treated with dapsone: review of the literature","volume":"142","author":"Ujiie","year":"2006","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0060|dth1508-cit-0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1529-8019.2007.00134.x","article-title":"Azathioprine: a guide for the management of dermatology patients","volume":"20","author":"Wise","year":"2007","journal-title":"Dermatol Ther"},{"issue":"10","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0061|dth1508-cit-0061","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/archderm.1985.01660100103026","article-title":"Successful treatment of generalized discoid skin lesions with azathioprine. Its use in a patient with systemic lupus erythematosus","volume":"121","author":"Tsokos","year":"1985","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0062|dth1508-cit-0062","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/archderm.1986.01660160026007","article-title":"Successful treatment of generalized discoid skin lesions with azathioprine","volume":"122","author":"Shehade","year":"1986","journal-title":"Arch Dermatol"},{"issue":"5 Pt 2","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0063|dth1508-cit-0063","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(88)70259-5","article-title":"Resistant discoid lupus erythematosus of palms and soles: successful treatment with azathioprine","volume":"19","author":"Ashinoff","year":"1988","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0064|dth1508-cit-0064","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/archderm.1991.04510010083008","article-title":"Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis","volume":"127","author":"Callen","year":"1991","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0065|dth1508-cit-0065","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1001\/archderm.138.12.1616","article-title":"Mycophenolate mofetil for the treatment of cutaneous lupus erythematosus with smoldering systemic involvement","volume":"138","author":"Hanjani","year":"2002","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0066|dth1508-cit-0066","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1067\/mjd.2001.114297","article-title":"Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil","volume":"45","author":"Goyal","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0067|dth1508-cit-0067","first-page":"393","article-title":"Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil","volume":"23","author":"Pisoni","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0068|dth1508-cit-0068","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1365-2133.2007.07826.x","article-title":"Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy","volume":"156","author":"Kreuter","year":"2007","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0069|dth1508-cit-0069","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaad.2010.08.011","article-title":"Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus","volume":"65","author":"Gammon","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0070|dth1508-cit-0070","doi-asserted-by":"crossref","first-page":"s9","DOI":"10.1177\/096120330501400103","article-title":"Mycophenolate mofetil and systemic lupus erythematosus: an overview","volume":"14","author":"Pisoni","year":"2005","journal-title":"Lupus"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0071|dth1508-cit-0071","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2133.2005.06747.x","article-title":"Thalidomide: dermatological indications, mechanisms of action and side-effects","volume":"153","author":"Wu","year":"2005","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0072|dth1508-cit-0072","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2133.1983.tb04600.x","article-title":"Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus","volume":"108","author":"Knop","year":"1983","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0073|dth1508-cit-0073","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-4362.2000.00953.x","article-title":"Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus","volume":"39","author":"Kyriakis","year":"2000","journal-title":"Int J Dermatol"},{"issue":"7","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0074|dth1508-cit-0074","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/08916930500285790","article-title":"Positive and negative effects of thalidomide on refractory cutaneous lupus erythematosus","volume":"38","author":"Briani","year":"2005","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0075|dth1508-cit-0075","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/0961203305lu2124oa","article-title":"Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus: a 65 series of Brazilian patients","volume":"14","author":"Coelho","year":"2005","journal-title":"Lupus"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0076|dth1508-cit-0076","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/09546630410018094","article-title":"Thalidomide treatment for hypertrophic cutaneous lupus erythematosus","volume":"15","author":"Gambini","year":"2004","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0077|dth1508-cit-0077","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0149-2918(00)88289-2","article-title":"S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomide","volume":"21","author":"Zeldis","year":"1999","journal-title":"Clin Ther"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0078|dth1508-cit-0078","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archdermatol.2009.30","article-title":"Lenalidomide for the treatment of resistant discoid lupus erythematosus","volume":"145","author":"Shah","year":"2009","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0079|dth1508-cit-0079","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1529-8019.2007.00142.x","article-title":"The use of i.v. IG therapy in dermatology","volume":"20","author":"Fernandez","year":"2007","journal-title":"Dermatol Ther"},{"issue":"9","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0080|dth1508-cit-0080","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archderm.135.9.1124","article-title":"High-dose intravenous immunoglobulin in cutaneous lupus erythematosus","volume":"135","author":"Genereau","year":"1999","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0081|dth1508-cit-0081","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/09546630310018789","article-title":"Intravenous immunoglobulin (IVIg) for therapy-resistant cutaneous lupus erythematosus (LE)","volume":"15","author":"Goodfield","year":"2004","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0082|dth1508-cit-0082","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/00015550510037071","article-title":"Intravenous immunoglobulin for recalcitrant subacute cutaneous lupus erythematosus","volume":"85","author":"Kreuter","year":"2005","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0083|dth1508-cit-0083","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10067-006-0222-5","article-title":"Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative","volume":"26","author":"Lampropoulos","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"2-3","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0084|dth1508-cit-0084","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12016-009-8162-x","article-title":"Intravenous immunoglobulin in lupus panniculitis","volume":"38","author":"Espirito Santo","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0085|dth1508-cit-0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2133.1971.tb14112.x","article-title":"Treatment of discoid and subacute lupus erythematosus with cyclophosphamide","volume":"85","author":"Schulz","year":"1971","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0086|dth1508-cit-0086","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/0961203309358601","article-title":"Pulse cyclophosphamide treatment for severe refractory cutaneous lupus erythematosus","volume":"19","author":"Raptopoulou","year":"2010","journal-title":"Lupus"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0087|dth1508-cit-0087","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0733-8635(05)70194-7","article-title":"Pulse intravenous cyclophosphamide therapy for dermatologic disorders","volume":"18","author":"Fox","year":"2000","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0088|dth1508-cit-0088","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1529-8019.2007.00137.x","article-title":"Systemic ciclosporin and tacrolimus in dermatology","volume":"20","author":"Madan","year":"2007","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0089|dth1508-cit-0089","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1191\/096120300678828406","article-title":"Maintaining remission of lupus erythematosus profundus (LEP) with cyclosporin A","volume":"9","author":"Saeki","year":"2000","journal-title":"Lupus"},{"issue":"9","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0090|dth1508-cit-0090","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/archderm.1986.01660210021007","article-title":"Cyclosporine in the treatment of lupus erythematosus","volume":"122","author":"Huele","year":"1986","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0091|dth1508-cit-0091","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2230.1995.tb01315.x","article-title":"Coexisting lichen planus and subacute cutaneous lupus erythematosus","volume":"20","author":"Grabbe","year":"1995","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0092|dth1508-cit-0092","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1440-0960.2010.00689.x","article-title":"Cyclosporin combined with methotrexate in two patients with recalcitrant subacute cutaneous lupus erythematosus","volume":"52","author":"Klein","year":"2011","journal-title":"Australas J Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0093|dth1508-cit-0093","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/00015550152573119","article-title":"Discoid lupus erythematosus in a patient receiving cyclosporine for liver transplantation","volume":"81","author":"Obermoser","year":"2001","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0094|dth1508-cit-0094","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-4632.2007.03333.x","article-title":"Leflunomide in subacute cutaneous lupus erythematosus - two sides of a coin","volume":"47","author":"Seuss","year":"2008","journal-title":"Int J Dermatol"},{"issue":"3 Suppl. 2","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0095|dth1508-cit-0095","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.jaad.2005.11.1090","article-title":"Case reports of etanercept in inflammatory dermatoses","volume":"54","author":"Norman","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0096|dth1508-cit-0096","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/art.10271","article-title":"Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor alpha-blocking agent: comment on the article by Pisetsky and the letter from Aringer et\u2009al.","volume":"46","author":"Fautrel","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0097|dth1508-cit-0097","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/rheumatology\/kep080","article-title":"Anti-TNF-induced lupus","volume":"48","author":"Williams","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0098|dth1508-cit-0098","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/rheumatology\/40.11.1317","article-title":"Etanercept-induced subacute cutaneous lupus erythematosus","volume":"40","author":"Bleumink","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0099|dth1508-cit-0099","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/rheumatology\/kel162","article-title":"Therapy-resistent lupus skin disease successfully treated with rituximab","volume":"45","author":"Risselada","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0100|dth1508-cit-0100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000112938","article-title":"Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case","volume":"216","author":"Uthman","year":"2008","journal-title":"Dermatology"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0101|dth1508-cit-0101","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1440-0960.2009.00539.x","article-title":"Refractory subacute cutaneous lupus erythematosus successfully treated with rituximab","volume":"50","author":"Kieu","year":"2009","journal-title":"Australas J Dermatol"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0102|dth1508-cit-0102","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10067-009-1158-3","article-title":"A case of \u201crefractory\u201d lupus erythematosus profundus responsive to rituximab (case report)","volume":"28","author":"McArdle","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0103|dth1508-cit-0103","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaad.2005.08.025","article-title":"Treatment of refractory subacute cutaneous lupus erythematosus with efalizumab","volume":"54","author":"Clayton","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0104|dth1508-cit-0104","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archderm.143.7.873","article-title":"Efalizumab in the treatment of discoid lupus erythematosus","volume":"143","author":"Usmani","year":"2007","journal-title":"Arch Dermatol"},{"issue":"14","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0105|dth1508-cit-0105","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1177\/0961203309106761","article-title":"Efalizumab for subacute cutaneous lupus: report of two different outcomes","volume":"18","author":"Sanchez-Cano","year":"2009","journal-title":"Lupus"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0106|dth1508-cit-0106","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejim.2010.03.004","article-title":"IL-17 in cutaneous lupus erythematosus","volume":"21","author":"Tanasescu","year":"2010","journal-title":"Eur J Intern Med"},{"issue":"8","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0107|dth1508-cit-0107","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/archdermatol.2011.185","article-title":"Successful treatment of subacute lupus erythematosus with ustekinumab","volume":"147","author":"De Souza","year":"2011","journal-title":"Arch Dermatol"},{"issue":"9767","key":"10.1111\/j.1529-8019.2012.01508.x-BIB1508-bib-0108|dth1508-cit-0108","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2012.01508.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2012.01508.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T11:15:14Z","timestamp":1714043714000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2012.01508.x"}},"subtitle":["Cutaneous lupus erythematosus"],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":108,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01508.x","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}